"10.1371_journal.pone.0063709","plos one","2013-05-21T00:00:00Z","Matthew W Mosconi; Beatriz Luna; Margaret Kay-Stacey; Caralynn V Nowinski; Leah H Rubin; Charles Scudder; Nancy Minshew; John A Sweeney","Departments of Psychiatry and Pediatrics, University of Texas Southwestern, Dallas, Texas, United States of America; Departments of Psychiatry and Psychology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States of America; Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States of America; Office of the Vice President for Research, University of Illinois, Urbana, Illinois, United States of America; Department of Psychiatry, University of Illinois at Chicago, Chicago, Illinois, United States of America; Departments of Otolaryngology and Neurobiology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States of America; Departments of Psychiatry and Neurology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States of America","Conceived and designed the experiments: BL CS NM JAS. Performed the experiments: BL CS NM JAS. Analyzed the data: MWM MKS CVN LHR CS JAS. Wrote the paper: MWM BL MKS CVN LHR CS NM JAS.","The authors have read the journal's policy and have the following conflicts: Drs. Mosconi, Luna, Kay-Stacey, Nowinski, Rubin, Scudder and Minshew reported no biomedical financial interests or potential conflicts of interest. Dr. Sweeney consults to Lilly, Takeda, Roche, BMS and Pfizer. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.",NA,NA,NA,"2013","05","Matthew W Mosconi","MWM",8,TRUE,4,4,6,8,TRUE,TRUE,FALSE,0,NA,FALSE
